These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

448 related articles for article (PubMed ID: 34219730)

  • 41. Cryptotanshinone Attenuates Amyloid-β
    Lyu D; Jia J
    Mol Neurobiol; 2022 Jul; 59(7):4488-4500. PubMed ID: 35575872
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Thamnolia vermicularis extract improves learning ability in APP/PS1 transgenic mice by ameliorating both Aβ and Tau pathologies.
    Li C; Guo XD; Lei M; Wu JY; Jin JZ; Shi XF; Zhu ZY; Rukachaisirikul V; Hu LH; Wen TQ; Shen X
    Acta Pharmacol Sin; 2017 Jan; 38(1):9-28. PubMed ID: 27694908
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cornel iridoid glycoside ameliorates cognitive deficits in APP/PS1/tau triple transgenic mice by attenuating amyloid-beta, tau hyperphosphorylation and neurotrophic dysfunction.
    Yang C; Bao X; Zhang L; Li Y; Li L; Zhang L
    Ann Transl Med; 2020 Mar; 8(6):328. PubMed ID: 32355772
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pharmacologic reversal of neurogenic and neuroplastic abnormalities and cognitive impairments without affecting Aβ and tau pathologies in 3xTg-AD mice.
    Blanchard J; Wanka L; Tung YC; Cárdenas-Aguayo Mdel C; LaFerla FM; Iqbal K; Grundke-Iqbal I
    Acta Neuropathol; 2010 Nov; 120(5):605-21. PubMed ID: 20697724
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Profile for amyloid-beta and tau expression in primary cortical cultures from 3xTg-AD mice.
    Vale C; Alonso E; Rubiolo JA; Vieytes MR; LaFerla FM; Giménez-Llort L; Botana LM
    Cell Mol Neurobiol; 2010 May; 30(4):577-90. PubMed ID: 19943189
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Alcohol drinking exacerbates neural and behavioral pathology in the 3xTg-AD mouse model of Alzheimer's disease.
    Hoffman JL; Faccidomo S; Kim M; Taylor SM; Agoglia AE; May AM; Smith EN; Wong LC; Hodge CW
    Int Rev Neurobiol; 2019; 148():169-230. PubMed ID: 31733664
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Toluidine blue O modifies hippocampal amyloid pathology in a transgenic mouse model of Alzheimer's disease.
    Yuksel M; Biberoglu K; Onder S; Akbulut KG; Tacal O
    Biochimie; 2018 Mar; 146():105-112. PubMed ID: 29248542
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ibuprofen reduces Abeta, hyperphosphorylated tau and memory deficits in Alzheimer mice.
    McKee AC; Carreras I; Hossain L; Ryu H; Klein WL; Oddo S; LaFerla FM; Jenkins BG; Kowall NW; Dedeoglu A
    Brain Res; 2008 May; 1207():225-36. PubMed ID: 18374906
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Insulin deficiency promotes formation of toxic amyloid-β42 conformer co-aggregating with hyper-phosphorylated tau oligomer in an Alzheimer's disease model.
    Imamura T; Yanagihara YT; Ohyagi Y; Nakamura N; Iinuma KM; Yamasaki R; Asai H; Maeda M; Murakami K; Irie K; Kira JI
    Neurobiol Dis; 2020 Apr; 137():104739. PubMed ID: 31927145
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Insulin-resistant brain state after intracerebroventricular streptozotocin injection exacerbates Alzheimer-like changes in Tg2576 AbetaPP-overexpressing mice.
    Plaschke K; Kopitz J; Siegelin M; Schliebs R; Salkovic-Petrisic M; Riederer P; Hoyer S
    J Alzheimers Dis; 2010; 19(2):691-704. PubMed ID: 20110613
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Long-term exposure to ELF-MF ameliorates cognitive deficits and attenuates tau hyperphosphorylation in 3xTg AD mice.
    Hu Y; Lai J; Wan B; Liu X; Zhang Y; Zhang J; Sun D; Ruan G; Liu E; Liu GP; Chen C; Wang DW
    Neurotoxicology; 2016 Mar; 53():290-300. PubMed ID: 26945731
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Passive immunization targeting the N-terminal projection domain of tau decreases tau pathology and improves cognition in a transgenic mouse model of Alzheimer disease and tauopathies.
    Dai CL; Chen X; Kazim SF; Liu F; Gong CX; Grundke-Iqbal I; Iqbal K
    J Neural Transm (Vienna); 2015 Apr; 122(4):607-17. PubMed ID: 25233799
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Metallothionein III Decreases the Proliferation of Astrocytes and Enhances Pathological Improvements in a Mouse Model of Alzheimer's Disease.
    Lv J; Wang F; Wang T; Shi Y
    Discov Med; 2024 Jun; 36(185):1221-1230. PubMed ID: 38926108
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Fibroblast growth factor 10 ameliorates neurodegeneration in mouse and cellular models of Alzheimer's disease via reducing tau hyperphosphorylation and neuronal apoptosis.
    Guo K; Huang W; Chen K; Huang P; Peng W; Shi R; He T; Zhang M; Wang H; Hu J; Wang X; Shentu Y; Xu H; Lin L
    Aging Cell; 2023 Sep; 22(9):e13937. PubMed ID: 37503695
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Nonhuman amyloid oligomer epitope reduces Alzheimer's-like neuropathology in 3xTg-AD transgenic mice.
    Rasool S; Martinez-Coria H; Milton S; Glabe CG
    Mol Neurobiol; 2013 Dec; 48(3):931-40. PubMed ID: 23771815
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Abnormal interaction of VDAC1 with amyloid beta and phosphorylated tau causes mitochondrial dysfunction in Alzheimer's disease.
    Manczak M; Reddy PH
    Hum Mol Genet; 2012 Dec; 21(23):5131-46. PubMed ID: 22926141
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Eriodictyol ameliorates cognitive dysfunction in APP/PS1 mice by inhibiting ferroptosis via vitamin D receptor-mediated Nrf2 activation.
    Li L; Li WJ; Zheng XR; Liu QL; Du Q; Lai YJ; Liu SQ
    Mol Med; 2022 Jan; 28(1):11. PubMed ID: 35093024
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Xanthoceraside rescues learning and memory deficits through attenuating beta-amyloid deposition and tau hyperphosphorylation in APP mice.
    Jin G; Wang LH; Ji XF; Chi TY; Qi Y; Jiao Q; Xu Q; Zhou XY; Zhang R; Zou LB
    Neurosci Lett; 2014 Jun; 573():58-63. PubMed ID: 24810883
    [TBL] [Abstract][Full Text] [Related]  

  • 59. α7 Nicotinic receptor agonist enhances cognition in aged 3xTg-AD mice with robust plaques and tangles.
    Medeiros R; Castello NA; Cheng D; Kitazawa M; Baglietto-Vargas D; Green KN; Esbenshade TA; Bitner RS; Decker MW; LaFerla FM
    Am J Pathol; 2014 Feb; 184(2):520-9. PubMed ID: 24269557
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Inhibition of PLK2 activity affects APP and tau pathology and improves synaptic content in a sex-dependent manner in a 3xTg mouse model of Alzheimer's disease.
    Martínez-Drudis L; Sheta R; Pellegrinato R; Loukili S; Tremblay C; Calon F; Rivest S; Oueslati A
    Neurobiol Dis; 2022 Oct; 172():105833. PubMed ID: 35905928
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.